In December 2008, Ibis Biosciences was acquired by Abbott Laboratories from which point, the firm is now operating as a subsiduary of Abbott Moclualr. Previous doing business as Ibis Technologies, the firm is organized around working on products for the identification and characterization of infectious agents, Ibis Biosciences had been a wholly owned subsidiary of Isis Pharmaceuticals. Ibis Biosciences has developed the Ibis T5000 Biosensor System, a hardware platform, and accompanying research assay kits, that have the potential to revolutionize the identification of infectious diseases. Ibis Biosciences employs a unique solution for the identification of biological organisms, including bacteria, viruses, fungi, and protozoa. It is also a powerful tool for human forensics